Because retatrutide has shown highly promising results in clinical trials, and works on three receptors rather than two, many expect it could be priced higher than Mounjaro if it is approved
An additional consideration is that the IGF-3/IGF-1 ratio may be an important factor determining the level of GH stimulation [3]

Wegovy, as an injection, is FDA approved to: Reduce excess body weight and maintain long-term weight reduction in: Adults with obesity and adolescents ages 12 years and older with obesity Adults with overweight plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol Treat a serious type of fatty liver disease called noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver scarring (stage F2 to F3 fibrosis) Lower the risk of major cardiovascular problems (such as heart attack, stroke, and heart-related death) in adults with established cardiovascular disease and obesity or overweight Contrave is FDA approved to: Reduce excess body weight and maintain long-term weight reduction in: Adults with obesity, defined as a body mass index (BMI) of 30 or higher Adults with a BMI of 27 or higher (overweight) plus at least one weight-related medical condition To recap, heres an at-a-glance comparison of FDA-approved uses for Wegovy vs

But the severity and character of bloating can differ between agents
J Clin Lipidol 20(1S):3854
ng gi sn phm cn thn thch Trm mua ti rocy.vn c xp hng 5 5 sao S ng h thm